New and emerging treatments for myasthenia gravis
Mckenzye DeHart-McCoyle, Shital M. Patel, Xinli Du
Abstract
### Key messages > New immunomodulatory therapeutics hold promise for the future treatment of myasthenia gravis, say DeHart-McCoyle and colleagues Myasthenia gravis is an antibody mediated autoimmune disorder affecting the function of the neuromuscular junction, leading to fluctuating weakness of
Topics & Concepts
Myasthenia gravisNeuromuscular junctionMedicineWeaknessMuscle weaknessImmunologyNeuroscienceBiologyInternal medicineSurgeryMyasthenia Gravis and ThymomaPeripheral Neuropathies and DisordersAutoimmune Neurological Disorders and Treatments